Logo image of FRE.DE

FRESENIUS SE & CO KGAA (FRE.DE) Stock Fundamental Analysis

Europe - Frankfurt Stock Exchange - FRA:FRE - DE0005785604 - Common Stock

49.03 EUR
+0.06 (+0.12%)
Last: 1/8/2026, 9:19:19 AM
Fundamental Rating

4

FRE gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 29 industry peers in the Health Care Providers & Services industry. FRE has an average financial health and profitability rating. FRE is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

In the past year FRE was profitable.
In the past year FRE had a positive cash flow from operations.
Of the past 5 years FRE 4 years were profitable.
FRE had a positive operating cash flow in each of the past 5 years.
FRE.DE Yearly Net Income VS EBIT VS OCF VS FCFFRE.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B

1.2 Ratios

FRE has a Return On Assets (2.69%) which is comparable to the rest of the industry.
FRE has a Return On Equity of 6.14%. This is comparable to the rest of the industry: FRE outperforms 48.28% of its industry peers.
The Return On Invested Capital of FRE (3.26%) is worse than 65.52% of its industry peers.
FRE had an Average Return On Invested Capital over the past 3 years of 1.83%. This is below the industry average of 6.33%.
The 3 year average ROIC (1.83%) for FRE is below the current ROIC(3.26%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 2.69%
ROE 6.14%
ROIC 3.26%
ROA(3y)0.52%
ROA(5y)1.33%
ROE(3y)2%
ROE(5y)5.13%
ROIC(3y)1.83%
ROIC(5y)2.61%
FRE.DE Yearly ROA, ROE, ROICFRE.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10

1.3 Margins

With an excellent Profit Margin value of 5.11%, FRE belongs to the best of the industry, outperforming 89.66% of the companies in the same industry.
FRE's Profit Margin has declined in the last couple of years.
With an excellent Operating Margin value of 9.76%, FRE belongs to the best of the industry, outperforming 86.21% of the companies in the same industry.
FRE's Operating Margin has declined in the last couple of years.
FRE has a Gross Margin of 24.99%. This is comparable to the rest of the industry: FRE outperforms 55.17% of its industry peers.
FRE's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 9.76%
PM (TTM) 5.11%
GM 24.99%
OM growth 3Y-9.84%
OM growth 5Y-8.98%
PM growth 3Y-23.64%
PM growth 5Y-16.51%
GM growth 3Y-3.58%
GM growth 5Y-3.36%
FRE.DE Yearly Profit, Operating, Gross MarginsFRE.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30

4

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), FRE is destroying value.
The number of shares outstanding for FRE remains at a similar level compared to 1 year ago.
FRE has more shares outstanding than it did 5 years ago.
FRE has a better debt/assets ratio than last year.
FRE.DE Yearly Shares OutstandingFRE.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M
FRE.DE Yearly Total Debt VS Total AssetsFRE.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B

2.2 Solvency

An Altman-Z score of 2.07 indicates that FRE is not a great score, but indicates only limited risk for bankruptcy at the moment.
With a Altman-Z score value of 2.07, FRE perfoms like the industry average, outperforming 51.72% of the companies in the same industry.
The Debt to FCF ratio of FRE is 11.17, which is on the high side as it means it would take FRE, 11.17 years of fcf income to pay off all of its debts.
FRE has a Debt to FCF ratio (11.17) which is in line with its industry peers.
A Debt/Equity ratio of 0.61 indicates that FRE is somewhat dependend on debt financing.
FRE has a better Debt to Equity ratio (0.61) than 82.76% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.61
Debt/FCF 11.17
Altman-Z 2.07
ROIC/WACC0.62
WACC5.27%
FRE.DE Yearly LT Debt VS Equity VS FCFFRE.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B

2.3 Liquidity

FRE has a Current Ratio of 1.26. This is a normal value and indicates that FRE is financially healthy and should not expect problems in meeting its short term obligations.
FRE's Current ratio of 1.26 is fine compared to the rest of the industry. FRE outperforms 68.97% of its industry peers.
FRE has a Quick Ratio of 1.26. This is a bad value and indicates that FRE is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.99, FRE is in the better half of the industry, outperforming 62.07% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.26
Quick Ratio 0.99
FRE.DE Yearly Current Assets VS Current LiabilitesFRE.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

4

3. Growth

3.1 Past

FRE shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 215.74%, which is quite impressive.
The Earnings Per Share has been decreasing by -2.29% on average over the past years.
FRE shows a small growth in Revenue. In the last year, the Revenue has grown by 2.13%.
Measured over the past years, FRE shows a decrease in Revenue. The Revenue has been decreasing by -9.22% on average per year.
EPS 1Y (TTM)215.74%
EPS 3Y-2.62%
EPS 5Y-2.29%
EPS Q2Q%20.29%
Revenue 1Y (TTM)2.13%
Revenue growth 3Y-16.51%
Revenue growth 5Y-9.22%
Sales Q2Q%2.22%

3.2 Future

Based on estimates for the next years, FRE will show a quite strong growth in Earnings Per Share. The EPS will grow by 10.63% on average per year.
Based on estimates for the next years, FRE will show a small growth in Revenue. The Revenue will grow by 4.90% on average per year.
EPS Next Y15%
EPS Next 2Y12.68%
EPS Next 3Y11.74%
EPS Next 5Y10.63%
Revenue Next Year4.48%
Revenue Next 2Y4.84%
Revenue Next 3Y4.86%
Revenue Next 5Y4.9%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
FRE.DE Yearly Revenue VS EstimatesFRE.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 10B 20B 30B 40B
FRE.DE Yearly EPS VS EstimatesFRE.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 1 2 3 4

4

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 14.38 indicates a correct valuation of FRE.
Based on the Price/Earnings ratio, FRE is valued a bit cheaper than 75.86% of the companies in the same industry.
FRE is valuated rather cheaply when we compare the Price/Earnings ratio to 26.92, which is the current average of the S&P500 Index.
With a Price/Forward Earnings ratio of 12.83, FRE is valued correctly.
FRE's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. FRE is cheaper than 72.41% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 23.57. FRE is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 14.38
Fwd PE 12.83
FRE.DE Price Earnings VS Forward Price EarningsFRE.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

FRE's Enterprise Value to EBITDA is on the same level as the industry average.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of FRE indicates a slightly more expensive valuation: FRE is more expensive than 68.97% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 23.03
EV/EBITDA 10.53
FRE.DE Per share dataFRE.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PEG (NY)0.96
PEG (5Y)N/A
EPS Next 2Y12.68%
EPS Next 3Y11.74%

3

5. Dividend

5.1 Amount

FRE has a Yearly Dividend Yield of 2.04%. Purely for dividend investing, there may be better candidates out there.
FRE's Dividend Yield is a higher than the industry average which is at 1.45.
FRE's Dividend Yield is comparable with the S&P500 average which is at 1.94.
Industry RankSector Rank
Dividend Yield 2.04%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
FRE.DE Yearly Dividends per shareFRE.DE Yearly Dividends per shareYearly Dividends per share 2016 2019 2020 2021 2022 2023 2025 0.5 1 1.5

5.3 Sustainability

59.84% of the earnings are spent on dividend by FRE. This is a bit on the high side, but may be sustainable.
DP59.84%
EPS Next 2Y12.68%
EPS Next 3Y11.74%
FRE.DE Yearly Income VS Free CF VS DividendFRE.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B 4B
FRE.DE Dividend Payout.FRE.DE Dividend Payout, showing the Payout Ratio.FRE.DE Dividend Payout.PayoutRetained Earnings

FRESENIUS SE & CO KGAA

FRA:FRE (1/8/2026, 9:19:19 AM)

49.03

+0.06 (+0.12%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)11-05 2025-11-05/bmo
Earnings (Next)03-25 2026-03-25/amc
Inst Owners46.56%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap27.62B
Revenue(TTM)22.35B
Net Income(TTM)1.14B
Analysts86.09
Price Target55.3 (12.79%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.04%
Yearly Dividend0
Dividend Growth(5Y)N/A
DP59.84%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)11.22%
Min EPS beat(2)8.91%
Max EPS beat(2)13.53%
EPS beat(4)4
Avg EPS beat(4)13.17%
Min EPS beat(4)8.91%
Max EPS beat(4)17.61%
EPS beat(8)5
Avg EPS beat(8)-25.39%
EPS beat(12)7
Avg EPS beat(12)-39.44%
EPS beat(16)8
Avg EPS beat(16)-31.03%
Revenue beat(2)1
Avg Revenue beat(2)-1.68%
Min Revenue beat(2)-4.68%
Max Revenue beat(2)1.31%
Revenue beat(4)3
Avg Revenue beat(4)0.47%
Min Revenue beat(4)-4.68%
Max Revenue beat(4)2.84%
Revenue beat(8)4
Avg Revenue beat(8)-0.27%
Revenue beat(12)4
Avg Revenue beat(12)-0.51%
Revenue beat(16)6
Avg Revenue beat(16)-0.27%
PT rev (1m)0.88%
PT rev (3m)7.95%
EPS NQ rev (1m)0.39%
EPS NQ rev (3m)-11.25%
EPS NY rev (1m)1.6%
EPS NY rev (3m)1.35%
Revenue NQ rev (1m)-0.05%
Revenue NQ rev (3m)0.1%
Revenue NY rev (1m)0.02%
Revenue NY rev (3m)-0.29%
Valuation
Industry RankSector Rank
PE 14.38
Fwd PE 12.83
P/S 1.24
P/FCF 23.03
P/OCF 12.69
P/B 1.48
P/tB 14.91
EV/EBITDA 10.53
EPS(TTM)3.41
EY6.95%
EPS(NY)3.82
Fwd EY7.79%
FCF(TTM)2.13
FCFY4.34%
OCF(TTM)3.87
OCFY7.88%
SpS39.68
BVpS33.06
TBVpS3.29
PEG (NY)0.96
PEG (5Y)N/A
Graham Number50.37
Profitability
Industry RankSector Rank
ROA 2.69%
ROE 6.14%
ROCE 6.63%
ROIC 3.26%
ROICexc 3.7%
ROICexgc 8.63%
OM 9.76%
PM (TTM) 5.11%
GM 24.99%
FCFM 5.37%
ROA(3y)0.52%
ROA(5y)1.33%
ROE(3y)2%
ROE(5y)5.13%
ROIC(3y)1.83%
ROIC(5y)2.61%
ROICexc(3y)1.84%
ROICexc(5y)2.65%
ROICexgc(3y)3.69%
ROICexgc(5y)5.83%
ROCE(3y)3.71%
ROCE(5y)5.33%
ROICexgc growth 3Y-17.75%
ROICexgc growth 5Y-15.4%
ROICexc growth 3Y-12.52%
ROICexc growth 5Y-11.09%
OM growth 3Y-9.84%
OM growth 5Y-8.98%
PM growth 3Y-23.64%
PM growth 5Y-16.51%
GM growth 3Y-3.58%
GM growth 5Y-3.36%
F-Score7
Asset Turnover0.53
Health
Industry RankSector Rank
Debt/Equity 0.61
Debt/FCF 11.17
Debt/EBITDA 3.4
Cap/Depr 86.4%
Cap/Sales 4.38%
Interest Coverage 6.84
Cash Conversion 65.69%
Profit Quality 104.9%
Current Ratio 1.26
Quick Ratio 0.99
Altman-Z 2.07
F-Score7
WACC5.27%
ROIC/WACC0.62
Cap/Depr(3y)72.62%
Cap/Depr(5y)76.65%
Cap/Sales(3y)6.17%
Cap/Sales(5y)6.12%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)215.74%
EPS 3Y-2.62%
EPS 5Y-2.29%
EPS Q2Q%20.29%
EPS Next Y15%
EPS Next 2Y12.68%
EPS Next 3Y11.74%
EPS Next 5Y10.63%
Revenue 1Y (TTM)2.13%
Revenue growth 3Y-16.51%
Revenue growth 5Y-9.22%
Sales Q2Q%2.22%
Revenue Next Year4.48%
Revenue Next 2Y4.84%
Revenue Next 3Y4.86%
Revenue Next 5Y4.9%
EBIT growth 1Y51.21%
EBIT growth 3Y-24.73%
EBIT growth 5Y-17.37%
EBIT Next Year65.95%
EBIT Next 3Y24.42%
EBIT Next 5Y15.57%
FCF growth 1Y-61.64%
FCF growth 3Y-21.04%
FCF growth 5Y-3.73%
OCF growth 1Y-52.6%
OCF growth 3Y-21.94%
OCF growth 5Y-10.74%

FRESENIUS SE & CO KGAA / FRE.DE FAQ

What is the fundamental rating for FRE stock?

ChartMill assigns a fundamental rating of 4 / 10 to FRE.DE.


What is the valuation status for FRE stock?

ChartMill assigns a valuation rating of 4 / 10 to FRESENIUS SE & CO KGAA (FRE.DE). This can be considered as Fairly Valued.


Can you provide the profitability details for FRESENIUS SE & CO KGAA?

FRESENIUS SE & CO KGAA (FRE.DE) has a profitability rating of 5 / 10.


What is the expected EPS growth for FRESENIUS SE & CO KGAA (FRE.DE) stock?

The Earnings per Share (EPS) of FRESENIUS SE & CO KGAA (FRE.DE) is expected to grow by 15% in the next year.


How sustainable is the dividend of FRESENIUS SE & CO KGAA (FRE.DE) stock?

The dividend rating of FRESENIUS SE & CO KGAA (FRE.DE) is 3 / 10 and the dividend payout ratio is 59.84%.